New heart failure pill shows promise in Mid-Stage trial
Disease control
Ongoing
This study tests an experimental pill called JTT-861 in 314 adults with chronic heart failure and a weakened heart pump. Participants take the drug or a placebo once daily for 12 weeks, alongside their usual heart medications. The goal is to see if the drug improves heart functio…
Phase: PHASE2 • Sponsor: Akros Pharma Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC